Linked Life Data

19893201

Source:http://linkedlifedata.com/resource/pubmed/id/19893201

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-11-6
pubmed:abstractText
Glatiramer acetate (GA, Copaxone) has beneficial effects on the clinical course of relapsing-remitting multiple sclerosis (RRMS). However, the exact molecular mechanisms of GA effects are only partially understood.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1875-8630
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
63-73
pubmed:meshHeading
pubmed-meshheading:19893201-Adult, pubmed-meshheading:19893201-Apoptosis, pubmed-meshheading:19893201-Biological Markers, pubmed-meshheading:19893201-Cell Adhesion, pubmed-meshheading:19893201-Female, pubmed-meshheading:19893201-Gene Expression Profiling, pubmed-meshheading:19893201-Humans, pubmed-meshheading:19893201-Immunosuppressive Agents, pubmed-meshheading:19893201-Inflammation, pubmed-meshheading:19893201-Male, pubmed-meshheading:19893201-Multiple Sclerosis, Relapsing-Remitting, pubmed-meshheading:19893201-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:19893201-Peptides, pubmed-meshheading:19893201-Prospective Studies, pubmed-meshheading:19893201-RNA, Messenger, pubmed-meshheading:19893201-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:19893201-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis.
pubmed:affiliation
Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Israel. achiron@post.tau
pubmed:publicationType
Journal Article, Randomized Controlled Trial